Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
City of Hope Medical Center
Takeda
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Wake Forest University Health Sciences
AIDS Malignancy Consortium
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
BeiGene
Celgene
Northwestern University
Pfizer
Kyowa Kirin Co., Ltd.
Emergent BioSolutions
Memorial Sloan Kettering Cancer Center
University of Nebraska
City of Hope Medical Center
Columbia University
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
Rhizen Pharmaceuticals SA
National Institutes of Health Clinical Center (CC)
miRagen Therapeutics, Inc.
Alexion Pharmaceuticals, Inc.
Brown University
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Spectrum Pharmaceuticals, Inc
National Institutes of Health Clinical Center (CC)
Stanford University
Weprom
Takeda
Eli Lilly and Company
Yale University
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Celgene
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Celgene
Fred Hutchinson Cancer Center